Clinical Trial Update: A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating recombinant human erythropoietin beta (NeoRecormon) for anemia in cancer patients treated with chemotherapy; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• NeoRecormon (epoetin beta)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: COMPLETED | Results posted: 2017-04-04